North America CRISPR Gene Editing Market 2021-2031 by Offering (Products, Services), Application (Biomedical, Agriculture, Industrial, Others), End User (Pharmaceutical Companies, Biotechnology Companies, Academic Institutions & Research Centers, Others), and Country: Trend Forecast and Growth Opportunity

About the Report

About the Report

North America CRISPR Gene Editing market is projected to grow by 24.4% annually in the forecast period and reach USD 5,976.7 million by 2031, driven by the rising demand for better food and medical products, innovative advancement in gene therapy supported by the continued investments in healthcare, rising geriatric population and the increasing genomic and chronic diseases, and the development of rapid CRISPR-based POC tests amid COVID-19 pandemic.

Highlighted with 28 tables and 50 figures, this 118-page report North America CRISPR Gene Editing Market 2021-2031 by Offering (Products, Services), Application (Biomedical, Agriculture, Industrial, Others), End User (Pharmaceutical Companies, Biotechnology Companies, Academic Institutions & Research Centers, Others), and Country: Trend Forecast and Growth Opportunity is based on a comprehensive research of the entire North America CRISPR Gene Editing market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

Market Structure

Growth Drivers

Restraints and Challenges

Emerging Product Trends & Market Opportunities

Porter's Fiver Forces

The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify North America CRISPR Gene Editing market in every aspect of the classification from perspectives of Offering, Application, End User, and Country.

Based on Offering, the North America market is segmented into the following sub-markets with annual revenue (USD mn) for 2021-2031 included in each section.

CRISPR Products

o Kits & Enzymes

Vector-Based Cas9

DNA-Free Cas9

o Databases & Libraries

o Design Tools

o Antibodies

o CRISPR Plasmid & Vector

o Other Products

CRISPR Services

o gRNA Design & Vector Construction

o Cell Line Engineering

o Microbial Gene Editing

o DNA Synthesis

o Other Services

Based on Application, the North America market is segmented into the following sub-markets with annual revenue (USD mn) for 2021-2031 included in each section.

Biomedical Research & Therapy

o Gene Therapy

o Drug Discovery

o Diagnostics

o Other Biomedical Applications

Agriculture

Industrial Use

Other Applications

By End User, the North America market is segmented into the following sub-markets with annual revenue (USD mn) for 2021-2031 included in each section.

Pharmaceutical Companies

Biotechnology Companies

Academic Institutions & Research Centers

Other End Users

Geographically, the following national/local markets are fully investigated:

U.S.

Canada

Mexico

For each key country, detailed analysis and data for annual revenue (USD mn) are available for 2021-2031. The breakdown of key national markets by Offering, Application, and End User, over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Selected Key Players:

Abcam, Inc.

Agilent Technologies, Inc.

Applied StemCell, Inc.

Caribou Biosciences, Inc.

Cellecta, Inc.

CRISPR Therapeutics AG

Editas Medicine, Inc.

GeneCopoeia, Inc.

GeneScript Biotech Corporation

Horizon Discovery Group PLC

Integrated DNA Technologies, Inc.

Intellia Therapeutics Inc.

Lonza Group Ltd.

Merck KGaA

New England Biolabs, Inc.

Origene Technologies, Inc.

Rockland Immunochemicals, Inc.

Synthego Corporation

System Biosciences LLC

Takara Bio, Inc.

Thermo Fisher Scientific, Inc.

ToolGen, Inc.

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Products


Companies

Selected Key Players:

Abcam, Inc.

Agilent Technologies, Inc.

Applied StemCell, Inc.

Caribou Biosciences, Inc.

Cellecta, Inc.

CRISPR Therapeutics AG

Editas Medicine, Inc.

GeneCopoeia, Inc.

GeneScript Biotech Corporation

Horizon Discovery Group PLC

Integrated DNA Technologies, Inc.

Intellia Therapeutics Inc.

Lonza Group Ltd.

Merck KGaA

New England Biolabs, Inc.

Origene Technologies, Inc.

Rockland Immunochemicals, Inc.

Synthego Corporation

System Biosciences LLC

Takara Bio, Inc.

Thermo Fisher Scientific, Inc.

ToolGen, Inc.

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Table of Contents

Table of Contents

1 Introduction 7

1.1 Industry Definition and Research Scope 7

1.1.1 Industry Definition 7

1.1.2 Research Scope 9

1.2 Research Methodology 12

1.2.1 Overview of Market Research Methodology 12

1.2.2 Market Assumption 13

1.2.3 Secondary Data 13

1.2.4 Primary Data 13

1.2.5 Data Filtration and Model Design 14

1.2.6 Market Size/Share Estimation 15

1.2.7 Research Limitations 16

1.3 Executive Summary 17

2 Market Overview and Dynamics 19

2.1 Market Size and Forecast 19

2.1.1 Impact of COVID-19 on World Economy 22

2.1.2 Impact of COVID-19 on the Market 24

2.2 Major Growth Drivers 26

2.3 Market Restraints and Challenges 35

2.4 Emerging Opportunities and Market Trends 38

2.5 Porter's Fiver Forces Analysis 42

3 Segmentation of North America Market by Offering 46

3.1 Market Overview by Offering 46

3.2 CRISPR Products 48

3.2.1 Kits & Enzymes 50

3.2.2 Databases & Libraries 51

3.2.3 Design Tools 52

3.2.4 Antibodies 53

3.2.5 CRISPR Plasmid & Vector 54

3.2.6 Other Products 55

3.3 CRISPR Services 56

3.3.1 gRNA Design & Vector Construction 58

3.3.2 Cell Line Engineering 59

3.3.3 Microbial Gene Editing 60

3.3.4 DNA Synthesis 61

3.3.5 Other Services 62

4 Segmentation of North America Market by Application 63

4.1 Market Overview by Application 63

4.2 Biomedical Research & Therapy 65

4.2.1 Gene Therapy 67

4.2.2 Drug Discovery 68

4.2.3 Diagnostics 69

4.2.4 Other Biomedical Applications 70

4.3 Agriculture 71

4.4 Industrial Use 72

4.5 Other Applications 73

5 Segmentation of North America Market by End User 74

5.1 Market Overview by End User 74

5.2 Pharmaceutical Companies 76

5.3 Biotechnology Companies 77

5.4 Academic Institutions & Research Centers 78

5.5 Other End Users 79

6 North America Market 2021-2031 by Country 80

6.1 Overview of North America Market 80

6.2 U.S. 83

6.3 Canada 86

6.4 Mexico 88

7 Competitive Landscape 89

7.1 Overview of Key Vendors 90

7.2 New Product Launch, Partnership, Investment, and M&A 94

7.3 Company Profiles 95

Abcam, Inc. 95

Agilent Technologies, Inc. 97

Applied StemCell, Inc. 98

Caribou Biosciences, Inc. 99

Cellecta, Inc. 100

CRISPR Therapeutics AG 101

Editas Medicine, Inc. 102

GeneCopoeia, Inc. 103

GeneScript Biotech Corporation 104

Horizon Discovery Group PLC 105

Integrated DNA Technologies, Inc. 106

Intellia Therapeutics Inc. 107

Lonza Group Ltd. 108

Merck KGaA 109

New England Biolabs, Inc. 110

Origene Technologies, Inc. 111

Rockland Immunochemicals, Inc. 112

Synthego Corporation 113

System Biosciences LLC 114

Takara Bio, Inc. 115

Thermo Fisher Scientific, Inc. 116

ToolGen, Inc. 117

RELATED REPORTS 118


List of Figure

List of Figures:

Figure 1. Research Method Flow Chart 12

Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 15

Figure 3. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031 17

Figure 4. North America CRISPR Gene Editing Market, 2021-2031, USD mn 19

Figure 5. Categories of CRISPR-Cas Systems 20

Figure 6. Impact of COVID-19 on Business 24

Figure 7. Primary Drivers and Impact Factors of North America CRISPR Gene Editing Market 26

Figure 8. Leading Causes of Death in the World, 2019-2020, million 32

Figure 9. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 33

Figure 10. World Population 65 and Over, % of Total Population, 1950-2060 33

Figure 11. Primary Restraints and Impact Factors of North America CRISPR Gene Editing Market 35

Figure 12. Investment Opportunity Analysis 39

Figure 13. Porter's Fiver Forces Analysis of North America CRISPR Gene Editing Market 42

Figure 14. Breakdown of North America CRISPR Gene Editing Market by Offering, 2021-2031, % of Revenue 47

Figure 15. North America Addressable Market Cap in 2022-2031 by Offering, Value (USD mn) and Share (%) 47

Figure 16. North America CRISPR Gene Editing Market by Offering: CRISPR Products, 2021-2031, USD mn 48

Figure 17. North America CRISPR Gene Editing Market by CRISPR Products: Kits & Enzymes, 2021-2031, USD mn 50

Figure 18. North America CRISPR Gene Editing Market by CRISPR Products: Databases & Libraries, 2021-2031, USD mn 51

Figure 19. North America CRISPR Gene Editing Market by CRISPR Products: Design Tools, 2021-2031, USD mn 52

Figure 20. North America CRISPR Gene Editing Market by CRISPR Products: Antibodies, 2021-2031, USD mn 53

Figure 21. North America CRISPR Gene Editing Market by CRISPR Products: CRISPR Plasmid & Vector, 2021-2031, USD mn 54

Figure 22. North America CRISPR Gene Editing Market by CRISPR Products: Other Products, 2021-2031, USD mn 55

Figure 23. North America CRISPR Gene Editing Market by Offering: CRISPR Services, 2021-2031, USD mn 56

Figure 24. North America CRISPR Gene Editing Market by CRISPR Services: gRNA Design & Vector Construction, 2021-2031, USD mn 58

Figure 25. North America CRISPR Gene Editing Market by CRISPR Services: Cell Line Engineering, 2021-2031, USD mn 59

Figure 26. North America CRISPR Gene Editing Market by CRISPR Services: Microbial Gene Editing, 2021-2031, USD mn 60

Figure 27. North America CRISPR Gene Editing Market by CRISPR Services: DNA Synthesis, 2021-2031, USD mn 61

Figure 28. North America CRISPR Gene Editing Market by CRISPR Services: Other Services, 2021-2031, USD mn 62

Figure 29. Breakdown of North America CRISPR Gene Editing Market by Application, 2021-2031, % of Sales Revenue 64

Figure 30. North America Addressable Market Cap in 2022-2031 by Application, Value (USD mn) and Share (%) 64

Figure 31. North America CRISPR Gene Editing Market by Application: Biomedical Research & Therapy, 2021-2031, USD mn 65

Figure 32. North America CRISPR Gene Editing Market by Biomedical Research & Therapy: Gene Therapy, 2021-2031, USD mn 67

Figure 33. North America CRISPR Gene Editing Market by Biomedical Research & Therapy: Drug Discovery, 2021-2031, USD mn 68

Figure 34. North America CRISPR Gene Editing Market by Biomedical Research & Therapy: Diagnostics, 2021-2031, USD mn 69

Figure 35. North America CRISPR Gene Editing Market by Biomedical Research & Therapy: Other Biomedical Applications, 2021-2031, USD mn 70

Figure 36. North America CRISPR Gene Editing Market by Application: Agriculture, 2021-2031, USD mn 71

Figure 37. North America CRISPR Gene Editing Market by Application: Industrial Use, 2021-2031, USD mn 72

Figure 38. North America CRISPR Gene Editing Market by Application: Other Applications, 2021-2031, USD mn 73

Figure 39. Breakdown of North America CRISPR Gene Editing Market by End User, 2021-2031, % of Sales Revenue 75

Figure 40. North America Addressable Market Cap in 2022-2031 by End User, Value (USD mn) and Share (%) 75

Figure 41. North America CRISPR Gene Editing Market by End User: Pharmaceutical Companies, 2021-2031, USD mn 76

Figure 42. North America CRISPR Gene Editing Market by End User: Biotechnology Companies, 2021-2031, USD mn 77

Figure 43. North America CRISPR Gene Editing Market by End User: Academic Institutions & Research Centers, 2021-2031, USD mn 78

Figure 44. North America CRISPR Gene Editing Market by End User: Other End Users, 2021-2031, USD mn 79

Figure 45. Breakdown of North America CRISPR Gene Editing Market by Country, 2021 and 2031, % of Revenue 81

Figure 46. Contribution to North America 2022-2031 Cumulative Market by Country, Value (USD mn) and Share (%) 82

Figure 47. U.S. CRISPR Gene Editing Market, 2021-2031, USD mn 84

Figure 48. Canada CRISPR Gene Editing Market, 2021-2031, USD mn 86

Figure 49. CRISPR Gene Editing Market in Mexico, 2021-2031, USD mn 88

Figure 50. Growth Stage of North America CRISPR Gene Editing Industry over the Forecast Period 90


List of Table

List of Tables:

Table 1. Snapshot of North America CRISPR Gene Editing Market in Balanced Perspective, 2021-2031 18

Table 2. World Economic Outlook, 2021-2031 23

Table 3. Developing Roadmap of CRISPR Technology 27

Table 4. Private and Public Companies Investment in CRISPR Technology 28

Table 5. Comparison of CRISPR with Other Gene Editing Technologies 31

Table 6. World Health Spending by Region, USD bn, 2013-2020 34

Table 7. Main Product Trends and Market Opportunities in North America CRISPR Gene Editing Market 38

Table 8. North America CRISPR Gene Editing Market by Offering, 2021-2031, USD mn 46

Table 9. North America CRISPR Gene Editing Market: CRISPR Products by Type, 2021-2031, USD mn 49

Table 10. North America CRISPR Gene Editing Market: Kits & Enzymes by Type, 2021-2031, USD mn 50

Table 11. North America CRISPR Gene Editing Market: CRISPR Services by Type, 2021-2031, USD mn 57

Table 12. North America CRISPR Gene Editing Market by Application, 2021-2031, USD mn 63

Table 13. North America CRISPR Gene Editing Market: Biomedical Research & Therapy by Type, 2021-2031, USD mn 66

Table 14. North America CRISPR Gene Editing Market by End User, 2021-2031, USD mn 74

Table 15. North America CRISPR Gene Editing Market by Country, 2021-2031, USD mn 81

Table 16. U.S. CRISPR Gene Editing Market by Offering, 2021-2031, USD mn 85

Table 17. U.S. CRISPR Gene Editing Market by Application, 2021-2031, USD mn 85

Table 18. U.S. CRISPR Gene Editing Market by End User, 2021-2031, USD mn 85

Table 19. Canada CRISPR Gene Editing Market by Offering, 2021-2031, USD mn 87

Table 20. Canada CRISPR Gene Editing Market by Application, 2021-2031, USD mn 87

Table 21. Canada CRISPR Gene Editing Market by End User, 2021-2031, USD mn 87

Table 22. Mexico CRISPR Gene Editing Market by Offering, 2021-2031, USD mn 89

Table 23. Mexico CRISPR Gene Editing Market by Application, 2021-2031, USD mn 89

Table 24. Mexico CRISPR Gene Editing Market by End User, 2021-2031, USD mn 89

Table 25. Breakdown of World Market by Key Vendor, 2021, % 92

Table 26. Abcam, Inc.: Company Snapshot 95

Table 27. Abcam, Inc.: Business Segmentation 96

Table 28. Abcam, Inc.: Product Portfolio 96

You can also purchase parts of this report. Do you want to check out a section wise price list?

Why Buy From US?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022

What Our Clients Say About Us

Want the same for your business? Talk To Our Expert